The global ophthalmic devices market was valued at USD 25.04 billion in 2019 and is expected to reach USD 32.36 billion by 2027, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period. In 2019, North America led the ophthalmic devices market, holding a market share of 42.09%.

Global Ophthalmic Devices Market research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.

For More Information, Visit – https://www.fortunebusinessinsights.com/ophthalmic-devices-market-102187

The introduction of innovative equipment, consumables, and contact lenses has significantly increased the demand for ophthalmic devices among healthcare providers and patients. For example, micro-invasive glaucoma surgery (MIGS) implants have emerged as one of the fastest-growing technologies for managing mild to moderate glaucoma. These advanced implants offer high efficacy and are expected to bridge the gap in glaucoma treatment.

Key players covered in the global Ophthalmic Devices Market research report:

• Alcon (Geneva, Switzerland)
• Carl Zeiss Meditec (Oberkochen, Germany)
• Johnson & Johnson Vision Care, Inc. (Jacksonville, U.S.)
• The Cooper Companies Inc. (California, U.S.)
• BVI (Waltham, U.S.)
• Bausch & Lomb Incorporated (Rochester, U.S.)
• Essilor (California, U.S.)
• Hoya Corporation (Tokyo, Japan)
• NIDEK CO., LTD (Gamagori, Japan)